The Valley Desk

ArticleClinical therapeuticsPublished

Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: Analysis of Number Needed To Treat and Number Needed To Harm

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Clinical therapeutics
Published
Subject terms
Esophagogastric Junction; Humans; Adenocarcinoma; Esophageal Neoplasms; Stomach Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Nivolumab; Stomach neoplasms; Treatment outcome
PubMed ID
37748935
Added to directory
Source checked

Report a correction or request removal